🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Stage IVB Lung Cancer

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer NCT05493566EARLY Phase 11 site📍 Atlanta Emory University · Tests: Aldesleukin, Pembrolizumab Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery NCT03582124Phase 1, Phase 21 site📍 Palo Alto Stanford University · Tests: Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study, Therapeutic Conventional Surgery Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) NCT06793813Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: cadonilimab，bevacizumab，docetaxel Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer NCT04762199Phase 11 site📍 Atlanta Emory University · Tests: Flt3/MerTK Inhibitor MRX-2843, Osimertinib Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer NCT04919382Phase 25 sites📍 Chicago📍 Indianapolis📍 Iowa City Dwight Owen · Tests: Atezolizumab, Temozolomide Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer NCT04780568Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Osimertinib, Tegavivint, Echocardiography Test, Multigated Acquisition Scan, Computed Tomography Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers NCT03948100NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Yoga PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer NCT05234307Phase 11 site📍 Columbus Dwight Owen · Tests: Adenosine A2B Receptor Antagonist PBF-1129, Biospecimen Collection, Nivolumab Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy